Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19- Infection With SARS-CoV-2 Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06528119
What this trial is testing

The Combined Usage of Clinical Physical Finding in Management of COVID 19 Patients

Who this might be right for
COVID-19 Pandemic
St. Martin De Porress Hospital 10,000
Large-scale testing (Phase 3)Study completedNCT05780463
What this trial is testing

MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 485
Not applicableStudy completedNCT04655638
What this trial is testing

HFNT vs. COT in COVID-19

Who this might be right for
Covid19Acute Respiratory Failure
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo 364
Testing effectiveness (Phase 2)Study completedNCT04357808
What this trial is testing

Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID)

Who this might be right for
Covid-19
Maria del Rosario Garcia de Vicuña Pinedo 30
Large-scale testing (Phase 3)Study completedNCT04362813
What this trial is testing

Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia

Who this might be right for
Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia
Novartis Pharmaceuticals 454
Not applicableStudy completedNCT06503874
What this trial is testing

Improving Attention in Individuals With Long COVID-19

Who this might be right for
Long Covid
Shirley Ryan AbilityLab 58
Testing effectiveness (Phase 2)Study completedNCT04387760
What this trial is testing

Favipiravir vs Hydroxychloroquine vs Control in COVID -19

Who this might be right for
SARS-CoV 2COVID-19
Royal College of Surgeons in Ireland - Medical University of Bahrain 150
Large-scale testing (Phase 3)Active Not RecruitingNCT04948203
What this trial is testing

Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis

Who this might be right for
Pulmonary FibrosisCOVID-19 PneumoniaLong COVID
University of Chicago 60
Testing effectiveness (Phase 2)UnknownNCT05113810
What this trial is testing

The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19

Who this might be right for
2019 Novel Coronavirus
Ministry of Health Jordan 110
Not applicableStudy completedNCT04345159
What this trial is testing

Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease

Who this might be right for
SARS-CoV-2Systemic Lupus ErythematosusRheumatoid Arthritis+2 more
Fondation Ophtalmologique Adolphe de Rothschild 572
Post-approval studies (Phase 4)Study completedNCT04801888
What this trial is testing

Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine

Who this might be right for
COVID-19Influenza
Sinovac Research and Development Co., Ltd. 480
Testing effectiveness (Phase 2)Study completedNCT04407182
What this trial is testing

Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19

Who this might be right for
Covid-19Sars-CoV2Diabete Mellitus+4 more
Catalysis SL 60
Testing effectiveness (Phase 2)Study completedNCT05960097
What this trial is testing

A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

Who this might be right for
SARS-CoV-2COVID-19
GlaxoSmithKline 692
Early research (Phase 1)Ended earlyNCT04397796
What this trial is testing

Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation

Who this might be right for
COVID
ImmunityBio, Inc. 4
Large-scale testing (Phase 3)UnknownNCT05222425
What this trial is testing

Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3

Who this might be right for
Sars-cov-2
Biomad AS 3,000
Testing effectiveness (Phase 2)Study completedNCT04920916
What this trial is testing

Safety and Efficacy of Dupilumab for Treatment of Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
University of Virginia 40
Large-scale testing (Phase 3)UnknownNCT04554433
What this trial is testing

New Treatment for COVID-19 Using Ethanol Vapor Inhalation .

Who this might be right for
Covid-19Drug Effect
Mansoura University 80
Not applicableUnknownNCT05725538
What this trial is testing

Exercise Intervention Using mHealth in Patients With Post-Acute COVID-19 Syndrome: a Randomized Clinical Trial

Who this might be right for
Post-Acute COVID19 SyndromeLong COVIDPost COVID-19 Condition
University of Cadiz 100
Large-scale testing (Phase 3)Study completedNCT05999435
What this trial is testing

Study of LAU-7b for the Treatment of Long COVID in Adults

Who this might be right for
Long COVID
Laurent Pharmaceuticals Inc. 272
Not applicableStudy completedNCT04425616
What this trial is testing

SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer

Who this might be right for
CancerCOVID
University Hospital Southampton NHS Foundation Trust 1,100
Next Page